CA3063842A1 - Novel peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient - Google Patents
Novel peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient Download PDFInfo
- Publication number
- CA3063842A1 CA3063842A1 CA3063842A CA3063842A CA3063842A1 CA 3063842 A1 CA3063842 A1 CA 3063842A1 CA 3063842 A CA3063842 A CA 3063842A CA 3063842 A CA3063842 A CA 3063842A CA 3063842 A1 CA3063842 A1 CA 3063842A1
- Authority
- CA
- Canada
- Prior art keywords
- gly
- leu
- ala
- pro
- yde
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/02—Linear peptides containing at least one abnormal peptide link
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20170061250 | 2017-05-17 | ||
| KR10-2017-0061250 | 2017-05-17 | ||
| PCT/KR2018/005673 WO2018225961A1 (ko) | 2017-05-17 | 2018-05-17 | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3063842A1 true CA3063842A1 (en) | 2019-12-09 |
Family
ID=64566301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3063842A Pending CA3063842A1 (en) | 2017-05-17 | 2018-05-17 | Novel peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US12037415B2 (https=) |
| EP (1) | EP3643723B1 (https=) |
| JP (2) | JP7680824B2 (https=) |
| KR (2) | KR102287226B1 (https=) |
| CN (1) | CN110945012A (https=) |
| AU (1) | AU2018281617B2 (https=) |
| BR (1) | BR112019024040A2 (https=) |
| CA (1) | CA3063842A1 (https=) |
| ES (1) | ES2982308T3 (https=) |
| MX (1) | MX2019013799A (https=) |
| RU (1) | RU2766160C2 (https=) |
| SG (1) | SG11201912110YA (https=) |
| WO (1) | WO2018225961A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102287226B1 (ko) | 2017-05-17 | 2021-08-11 | 주식회사 유유제약 | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| JP7576048B2 (ja) * | 2019-05-21 | 2024-10-30 | アイバイオ コリア | 新規なペプチド化合物またはその薬学的に許容される塩 |
| KR20210104460A (ko) * | 2020-02-17 | 2021-08-25 | 주식회사 아이바이오코리아 | 고체상 합성법을 이용한 펩타이드의 제조 방법 |
| EP4114430A4 (en) * | 2020-03-05 | 2025-05-14 | YUYU Pharma, Inc. | TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS |
| KR102593936B1 (ko) * | 2021-12-13 | 2023-10-27 | 주식회사 아이바이오코리아 | 신규한 펩타이드를 포함하는 황반변성의 치료용 조성물 |
| AU2022412618B2 (en) * | 2021-12-13 | 2026-02-19 | Eyebiokorea, Inc. | Composition for treating macular degeneration comprising novel peptide |
| KR102587729B1 (ko) * | 2023-02-27 | 2023-10-12 | 주식회사 아이바이오코리아 | 펩타이드를 포함하는 당뇨망막병증의 치료용 조성물 |
| KR102673860B1 (ko) * | 2023-08-10 | 2024-06-12 | (주)케어젠 | 안구 건조증의 개선 활성을 갖는 펩타이드 및 이의 용도 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6037135A (en) * | 1992-08-07 | 2000-03-14 | Epimmune Inc. | Methods for making HLA binding peptides and their uses |
| WO2007117444A2 (en) * | 2006-03-31 | 2007-10-18 | Yinghe Hu | Protein detection by aptamers |
| US10611818B2 (en) | 2007-09-27 | 2020-04-07 | Agilent Technologies, Inc. | MHC multimers in tuberculosis diagnostics, vaccine and therapeutics |
| US20090131303A1 (en) * | 2007-11-16 | 2009-05-21 | Bor-Shyue Hong | Methods and compositions for treating dry eye |
| JP4490498B2 (ja) | 2008-09-30 | 2010-06-23 | 新田ゼラチン株式会社 | 疾病抑制剤 |
| CA2836946C (en) * | 2011-05-27 | 2017-08-01 | Allergan, Inc. | A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof |
| MX2014006399A (es) * | 2011-11-30 | 2015-04-10 | Xigen Inflammation Ltd | Uso de inhibidores de peptidos con celulas permeables de la via para transduccion de señal de jnk para el tratamiento de la queratoconjuntivitis seca. |
| KR101438744B1 (ko) * | 2012-08-02 | 2014-09-15 | 전남대학교산학협력단 | 아디포넥틴을 유효성분으로 포함하는 안구건조증 또는 염증성 안구표면 질환의 예방 또는 치료용 조성물 |
| KR101555296B1 (ko) | 2013-12-10 | 2015-09-23 | 인제대학교 산학협력단 | 연골세포 유래 세포외 기질을 유효성분으로 함유하는 건성안 예방 또는 치료용 약학조성물 |
| KR101948156B1 (ko) | 2013-12-10 | 2019-02-14 | 인제대학교 산학협력단 | 알칼리 화상을 이용한 각막 혼탁증 동물모델 및 각막 혼탁증 예방 또는 치료용 약학조성물 |
| KR101721059B1 (ko) | 2014-12-26 | 2017-03-30 | 주식회사 아이바이오코리아 | 안구 표면 질환 예방 또는 치료용 약학조성물 |
| KR101690539B1 (ko) | 2015-07-30 | 2016-12-29 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| TWI675851B (zh) | 2015-12-14 | 2019-11-01 | 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 | 短合成胜肽及其用途 |
| CN109310731B (zh) * | 2016-04-08 | 2022-03-29 | 韩国视角生物株式会社 | 软骨细胞的细胞外基质来源的肽 |
| KR101798183B1 (ko) * | 2016-04-08 | 2017-11-15 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 약학조성물 |
| KR101795653B1 (ko) | 2016-05-19 | 2017-11-09 | 인제대학교 산학협력단 | 콜라겐 타입 ii 펩타이드-아플리버셉트의 키메라 단백질을 유효성분으로 함유하는 혈관신생 억제용 조성물 |
| KR20180074928A (ko) | 2016-12-26 | 2018-07-04 | 주식회사 아이바이오코리아 | 건성안 예방 또는 치료용 동물 의약품 조성물 |
| KR102287226B1 (ko) | 2017-05-17 | 2021-08-11 | 주식회사 유유제약 | 신규한 펩타이드 및 이를 유효성분으로 포함하는 안구질환 치료용 약학 조성물 |
| TWI865470B (zh) * | 2018-11-14 | 2024-12-11 | 南韓商柳柳製藥股份有限公司 | 治療眼睛疾病之肽及醫藥組合物 |
| US11613558B2 (en) | 2018-11-14 | 2023-03-28 | Yuyu Pharma, Inc. | Peptides and pharmaceutical compositions for treating eye diseases |
| EP4114430A4 (en) * | 2020-03-05 | 2025-05-14 | YUYU Pharma, Inc. | TREATMENT OF INFLAMMATORY DISEASES WITH PEPTIDES AND PHARMACEUTICAL COMPOSITIONS |
-
2018
- 2018-05-17 KR KR1020180056745A patent/KR102287226B1/ko active Active
- 2018-05-17 BR BR112019024040-3A patent/BR112019024040A2/pt unknown
- 2018-05-17 EP EP18812841.7A patent/EP3643723B1/en active Active
- 2018-05-17 MX MX2019013799A patent/MX2019013799A/es unknown
- 2018-05-17 JP JP2019563617A patent/JP7680824B2/ja active Active
- 2018-05-17 SG SG11201912110YA patent/SG11201912110YA/en unknown
- 2018-05-17 RU RU2019141646A patent/RU2766160C2/ru active
- 2018-05-17 CN CN201880047540.1A patent/CN110945012A/zh active Pending
- 2018-05-17 US US16/614,123 patent/US12037415B2/en active Active
- 2018-05-17 WO PCT/KR2018/005673 patent/WO2018225961A1/ko not_active Ceased
- 2018-05-17 ES ES18812841T patent/ES2982308T3/es active Active
- 2018-05-17 CA CA3063842A patent/CA3063842A1/en active Pending
- 2018-05-17 AU AU2018281617A patent/AU2018281617B2/en active Active
-
2021
- 2021-07-30 KR KR1020210100394A patent/KR102498428B1/ko active Active
-
2023
- 2023-04-05 JP JP2023061251A patent/JP7775250B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018281617B2 (en) | 2022-06-30 |
| SG11201912110YA (en) | 2020-01-30 |
| EP3643723B1 (en) | 2024-05-15 |
| RU2019141646A3 (https=) | 2021-07-28 |
| ES2982308T3 (es) | 2024-10-15 |
| JP2023098936A (ja) | 2023-07-11 |
| RU2019141646A (ru) | 2021-06-17 |
| JP2020520372A (ja) | 2020-07-09 |
| CN110945012A (zh) | 2020-03-31 |
| US12037415B2 (en) | 2024-07-16 |
| BR112019024040A2 (pt) | 2020-09-24 |
| US20210024577A1 (en) | 2021-01-28 |
| RU2766160C2 (ru) | 2022-02-08 |
| EP3643723C0 (en) | 2024-05-15 |
| MX2019013799A (es) | 2020-08-13 |
| KR102498428B1 (ko) | 2023-02-20 |
| EP3643723A1 (en) | 2020-04-29 |
| AU2018281617A1 (en) | 2019-12-05 |
| KR20210097670A (ko) | 2021-08-09 |
| EP3643723A4 (en) | 2021-03-31 |
| WO2018225961A1 (ko) | 2018-12-13 |
| KR102287226B1 (ko) | 2021-08-11 |
| KR20180126406A (ko) | 2018-11-27 |
| JP7775250B2 (ja) | 2025-11-25 |
| JP7680824B2 (ja) | 2025-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3063842A1 (en) | Novel peptide and pharmaceutical composition for treating an eye disease comprising the same as an active pharmaceutical ingredient | |
| JP7522732B2 (ja) | 眼疾患治療用のペプチド及び医薬組成物 | |
| CA2746264C (en) | New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication | |
| CA2645072A1 (en) | Substituted aminothiazole derivatives with anti-hcv activity | |
| WO2021191689A2 (en) | Treatment of inflammatory diseases with peptides and pharmaceutical compositions | |
| TR201816372T4 (tr) | Enzim inhibisyonu için etoksiketon bileşikleri. | |
| KR102058853B1 (ko) | 지질화 펩타이드의 수용성 염과 이의 제조 방법 및 용도 | |
| JP7834361B2 (ja) | 置換４－（［１，２，４］トリアゾロ［１，５－ａ］ピリジン－６－イル）チオフェン－２－カルボキサミド誘導体及びその使用 | |
| HK40017864A (en) | Novel peptide and pharmaceutical composition for treatment of eye diseases comprising same novel peptide as active ingredient | |
| CA3119921C (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| RU2819399C2 (ru) | Пептиды и фармацевтические композиции для лечения глазных болезней | |
| CN105636956A (zh) | 作为细胞坏死阻碍剂的吲哚化合物 | |
| HK40061089A (en) | Peptides and pharmaceutical compositions for treating eye diseases | |
| HK40061089B (zh) | 用於治疗眼病的肽和药物组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20220927 |
|
| B12 | Application deemed to be withdrawn, abandoned or lapsed |
Free format text: ST27 STATUS EVENT CODE: N-2-6-B10-B12-B303 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO AN EXAMINER'S REQUISITION Effective date: 20240718 |